BioStorage Technologies Leads Global Sample Management Symposium at Annual Biorepositories Conference
FOR IMMEDIATE RELEASE
Press Contact:
Michael Clark
Miller Brooks, Inc.
317-873-8100
michael@millerbrooks.com
INDIANAPOLIS (September 11, 2012) – BioStorage Technologies, a global provider of comprehensive sample management solutions for the bioscience industry, including storage, cold chain logistics, virtual sample intelligence and bioprocessing solutions, will host its Global Sample Management Benchmarking Symposium in conjunction with the 5th annual Biorepositories Conference on Sept. 18, 2012 in Boston. The symposium will highlight strategies for achieving successful sample optimization through innovative outsourcing models, improved lifecycle management strategies and state-of-the-art technology solutions.
Strategic sample optimization is a process that focuses on global consolidation of sample assets and leverages technology to improve sample utilization, mitigate risk and increase return-on-investment. Optimizing the management of these research assets can provide biopharmaceutical companies with significant value from both a scientific and financial perspective.
“The lack of high-quality, clinically annotated human specimens is one of the principal limiting factors for translational research, therefore it’s imperative that we find the most effective ways to manage and store research assets in order to support the biopharmaceutical industry as they work towards new and innovative drug development,” said Gregory Swanberg, Chief Executive Officer, BioStorage Technologies. “BioStorage Technologies is proud to provide an educational platform to help facilitate these conversations as the industry continues to bring to light the significant value sample assets bring to a research organization.”
Attendees of the symposium will receive valuable information on how to:
- Extend sample management lifecycle strategies from consolidation to optimization of assets
- Leverage process and technology to virtually manage sample assets and associated data
- Evaluate and select the right sample management model and how to secure the buy-in from research scientists
- Reduce the cost of sample management while achieving research efficiencies, quality and speed to marke
The symposium’s expert panel includes:
- Debra Reinhard, Director, Clinical Sample Strategy & Operations, Bristol Myers Squibb
- Dr. Amelia Wall Warner, Head of Clinical Pharmacogenomics, Merck & Company
- Erik Billings, Director of Healthcare Product Management, Iron Mountain
- Steve Sweeney, Chief Executive Officer, Integrity Clinical Services
BioStorage Technologies will be exhibiting at the Biorepositories Conference, booth #204, and is also a leading sponsor for the event. Lori Ball, Chief Operating Officer, BioStorage Technologies, will be a co-chair for the two-day conference as well.
For more information on the Global Sample Management Benchmarking Symposium, visit www.biostorage.com/symposium.
About BioStorage Technologies, Inc.:
BioStorage Technologies, Inc. is the premier, global provider of comprehensive sample management solutions for the bioscience industry. Offering flexible onsite, offsite and hybrid sample outsourcing models for the management of research assets, BioStorage Technologies manages the complete life-cycle of samples. With an expert team of global sample consultants, industry-leading temperature-controlled storage facilities, and state-of-the-art virtual sample management and bioprocessing solutions, the company supports its customers in maximizing opportunities, minimizing risk and reducing costs. BioStorage Technologies, Inc. is privately held and headquartered in Indianapolis with an additional full-service site near Frankfurt, Germany and a wholly-owned division in Singapore. For more information, visit www.biostorage.com or call +1 (866) 697-2675 or +49-6155-898-1011.
